CIRRHOSIS, LIVER
Clinical trials for CIRRHOSIS, LIVER explained in plain language.
Never miss a new study
Get alerted when new CIRRHOSIS, LIVER trials appear
Sign up with your email to follow new studies for CIRRHOSIS, LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can text messages and lifestyle changes reverse early liver damage?
Disease control OngoingThis study tests whether a 6-month personalized lifestyle program can help improve liver health in people with early signs of liver disease. Participants receive guidance on diet, exercise, alcohol use, and medication adherence through text messages and support. The goal is to se…
Matched conditions: CIRRHOSIS, LIVER
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Exercise before liver transplant may speed recovery, study finds
Disease control ENROLLING_BY_INVITATIONThis study is testing whether a special exercise program before a liver transplant, and continued training after surgery, helps people recover better. It will involve 60 adults waiting for a transplant and measure how the program affects hospital stays, complications, strength, a…
Matched conditions: CIRRHOSIS, LIVER
Phase: NA • Sponsor: Maria dels Angels Cebria i Iranzo, PT, PhD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Antibiotic tested to clear 'Liver brain Fog'
Disease control TerminatedThis study aimed to see if the antibiotic rifaximin could improve subtle thinking problems (covert hepatic encephalopathy) in people with liver cirrhosis, especially when those problems are linked to an overgrowth of gut bacteria. The plan was to treat about 40 patients for eight…
Matched conditions: CIRRHOSIS, LIVER
Phase: PHASE3 • Sponsor: MetroHealth Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope to shield kidneys in High-Risk liver transplants
Disease control ENROLLING_BY_INVITATIONThis study is testing if a drug called angiotensin 2, given during liver transplant surgery, can prevent kidney injury afterward. It will involve about 30 adults with severe liver disease who are receiving a transplant. Half will get the study drug along with standard medications…
Matched conditions: CIRRHOSIS, LIVER
Phase: PHASE4 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Doctors question routine antibiotics after bleeding treatment
Disease control OngoingThis study aims to find out if preventive antibiotics are necessary for cirrhosis patients undergoing a follow-up endoscopic procedure to prevent variceal bleeding from happening again. It involves 226 patients who have a history of this type of bleeding. The research compares ou…
Matched conditions: CIRRHOSIS, LIVER
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
The hidden cost of liver disease: study tracks financial strain on families
Knowledge-focused OngoingThis study aims to understand the financial burden and stress experienced by patients with liver cirrhosis and their family caregivers. It follows 52 participants and their caregivers for 72 weeks, tracking out-of-pocket medical costs, lost work productivity, and overall financia…
Matched conditions: CIRRHOSIS, LIVER
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Massive study tracks liver patients to find best shunt practices
Knowledge-focused OngoingThis study aims to gather real-world information on a common procedure for liver cirrhosis called TIPS. It will follow 852 patients for up to 5 years after they get the shunt as part of their normal care. The goal is to create a database to answer key questions about how to best …
Matched conditions: CIRRHOSIS, LIVER
Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:07 UTC
-
Major study tracks 1,200 patients to predict liver failure
Knowledge-focused OngoingThis study aims to better understand which adults with liver cirrhosis are most at risk for serious health complications. It will follow over 1,200 participants with liver scarring, checking in with them every six months to collect health data, images, and samples. The goal is to…
Matched conditions: CIRRHOSIS, LIVER
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Hidden liver risk in diabetes: quick scan seeks silent scarring
Knowledge-focused OngoingThis study aims to find out how common fatty liver disease and serious liver scarring are in adults with type 1 diabetes. Researchers will screen over 500 patients using a quick, non-invasive scan and blood tests. The goal is to identify patients at high risk who may need to see …
Matched conditions: CIRRHOSIS, LIVER
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC